THE MEDICINES COMPANY

the-medicines-company-logo

The Medicines Company is focused on advancing the treatment of critical care patients through the delivery of innovative, cost-effective medicines to the worldwide hospital marketplace. The Company markets Angiomax(R) (bivalirudin) in the United States and other countries for use in patients undergoing coronary angioplasty, and Cleviprex(R) (clevidipine butyrate) injectable emulsion in the United States for the reduction of blood pressure when oral therapy is not feasible or not desirable. The Company also has two products in late stage development: cangrelor, an investigational antiplatelet agent, and oritavancin, a semi-synthetic lipoglycopeptide antibiotic. The Company's pipeline also includes a serine protease inhibitor, CU2010, in early-stage development.

#People #Financial #Website #More

THE MEDICINES COMPANY

Social Links:

Industry:
Biotechnology Health Care Pharmaceutical

Founded:
1996-01-01

Address:
Parsippany, New Jersey, United States

Country:
United States

Website Url:
http://www.themedicinescompany.com

Total Employee:
1001+

Status:
Closed

Contact:
(973) 290-6000

Email Addresses:
[email protected]

Total Funding:
0

Technology used in webpage:
Global Site Tag IPv6 CDN JS Cloudflare Hosting IIS IIS 7 Cookie Consent By Osano Silktide Cookie Consent ASP.NET 2.0 Akamai DNS



Current Advisors List

armin-kessler_image

Armin Kessler Member of the Board of Directors @ The Medicines Company
Board_member

robert-hugin_image

Robert Hugin Member of the Board of Directors @ The Medicines Company
Board_member

Current Employees Featured

mark-timney_image

Mark Timney
Mark Timney CEO & Member of the Board @ The Medicines Company
CEO & Member of the Board
2018-12-01

not_available_image

Elizabeth Morgan
Elizabeth Morgan VP. Clinical and RA/QA Operations @ The Medicines Company
VP. Clinical and RA/QA Operations
2012-12-01

rob-rode_image

Rob Rode
Rob Rode Independent Consultant @ The Medicines Company
Independent Consultant
2020-01-01

jeff-frazier_image

Jeff Frazier
Jeff Frazier Executive Vice President @ The Medicines Company
Executive Vice President

bruce-rosengard_image

Bruce Rosengard
Bruce Rosengard Vice President, New Business Ventures @ The Medicines Company
Vice President, New Business Ventures
2012-07-01

stephanie-plent_image

Stephanie Plent
Stephanie Plent Executive Vice President @ The Medicines Company
Executive Vice President

nancye-green_image

Nancye Green
Nancye Green Executive Vice President @ The Medicines Company
Executive Vice President

Founder


clive-meanwell_image

Clive Meanwell

Stock Details


Company's stock symbol is NASDAQ:MDCO

Acquisitions List

Date Company Article Price
2015-02-04 Annovation BioPharma Annovation BioPharma acquired by The Medicines Company N/A
2014-04-23 Tenaxis Medical Tenaxis Medical acquired by The Medicines Company N/A
2013-12-04 Rempex Pharmaceuticals Rempex Pharmaceuticals acquired by The Medicines Company 474 M USD
2013-08-05 ProFibrix ProFibrix acquired by The Medicines Company 240 M USD
2012-12-12 Incline Therapeutics Incline Therapeutics acquired by The Medicines Company N/A
2009-12-22 ApoA-I Milano ApoA-I Milano acquired by The Medicines Company N/A
2009-01-13 Targanta Therapeutics Targanta Therapeutics acquired by The Medicines Company 42 M USD
2008-08-05 Curacyte Discovery GmbH Curacyte Discovery GmbH acquired by The Medicines Company N/A

Investors List

hanseatic-asset-management_image

Hanseatic Asset Management

Hanseatic Asset Management investment in Venture Round - The Medicines Company

biotech-growth_image

Biotech Growth

Biotech Growth investment in Venture Round - The Medicines Company

credit-suisse_image

Credit Suisse

Credit Suisse investment in Venture Round - The Medicines Company

warburg-pincus_image

Warburg Pincus

Warburg Pincus investment in Venture Round - The Medicines Company

alta-partners_image

Alta Partners

Alta Partners investment in Venture Round - The Medicines Company

genechem_image

GeneChem

GeneChem investment in Venture Round - The Medicines Company

moore-capital_image

Moore Capital

Moore Capital investment in Venture Round - The Medicines Company

bancamerica-robertson-stephens_image

BancAmerica Robertson Stephens

BancAmerica Robertson Stephens investment in Venture Round - The Medicines Company

morgan-stanley-venture-partners_image

Morgan Stanley Venture Partners

Morgan Stanley Venture Partners investment in Venture Round - The Medicines Company

Official Site Inspections

http://www.themedicinescompany.com

  • Host name: 104.18.2.191
  • IP address: 104.18.2.191
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "The Medicines Company" on Search Engine